IRIS
RESTEGHINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.259
NA - Nord America 775
SA - Sud America 375
EU - Europa 160
AF - Africa 31
Totale 2.600
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 758
US - Stati Uniti d'America 723
BR - Brasile 330
CN - Cina 300
VN - Vietnam 58
HK - Hong Kong 42
IT - Italia 41
GB - Regno Unito 31
CA - Canada 30
DE - Germania 28
IN - India 26
AR - Argentina 21
BD - Bangladesh 14
MX - Messico 13
ZA - Sudafrica 13
PL - Polonia 11
EC - Ecuador 10
IQ - Iraq 9
RU - Federazione Russa 9
ID - Indonesia 8
JP - Giappone 8
SE - Svezia 8
ES - Italia 7
FR - Francia 7
PK - Pakistan 6
TR - Turchia 6
CO - Colombia 5
UZ - Uzbekistan 5
VE - Venezuela 5
IE - Irlanda 4
KE - Kenya 4
MA - Marocco 4
SA - Arabia Saudita 4
KZ - Kazakistan 3
NP - Nepal 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
EG - Egitto 2
NL - Olanda 2
OM - Oman 2
PY - Paraguay 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
FI - Finlandia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 2.600
Salva come PNG Salva come JPEG
Città #
Singapore 243
The Dalles 180
Shanghai 135
Beijing 122
Ashburn 96
Dallas 85
Hong Kong 38
Seattle 25
São Paulo 25
Ho Chi Minh City 23
Los Angeles 20
Boardman 19
Brooklyn 16
Montreal 15
Naples 14
New York 14
Rio de Janeiro 14
Hanoi 12
Düsseldorf 11
Santa Clara 11
Warsaw 10
Assago 8
Chennai 8
Johannesburg 8
Tokyo 8
Atlanta 7
Brasília 7
Milan 7
Stockholm 7
Belo Horizonte 6
Chicago 6
Curitiba 5
London 5
Mexico City 5
Munich 5
Phoenix 5
Portsmouth 5
San Francisco 5
Tashkent 5
Campinas 4
Caruaru 4
Cotia 4
Guayaquil 4
Haiphong 4
Nairobi 4
Orem 4
Porto Alegre 4
Ribeirão Preto 4
Salvador 4
Bengaluru 3
Buenos Aires 3
Buffalo 3
Conselheiro Lafaiete 3
Dublin 3
Duque de Caxias 3
Goiânia 3
Joinville 3
Mumbai 3
Paris 3
Quito 3
São José do Rio Preto 3
Tatuí 3
Toronto 3
Trieste 3
Uberlândia 3
Almaty 2
Ankara 2
Belo Jardim 2
Belém 2
Biên Hòa 2
Blumenau 2
Boston 2
Bridgetown 2
Cachoeirinha 2
Cajamar 2
Camaragibe 2
Camaçari 2
Campinas do Sul 2
Cape Town 2
Caraguatatuba 2
Cariacica 2
Cincinnati 2
City of London 2
Cubatão 2
Da Nang 2
Denver 2
Erbil 2
Erechim 2
Faisalabad 2
Fortaleza 2
Genoa 2
Glasgow 2
Guarulhos 2
Hyderabad 2
Istanbul 2
Jakarta 2
Jaú 2
Jeddah 2
Jundiaí 2
Kathmandu 2
Totale 1.398
Salva come PNG Salva come JPEG
Nome #
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 77
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 64
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 45
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 45
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 44
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 38
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting 36
Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient 36
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment 36
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) 36
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol 34
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure 34
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients? 34
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 34
Big Data in Head and Neck Cancer 33
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 33
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 33
Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma 32
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). 31
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 31
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients 30
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era 30
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 30
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 30
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial 29
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 29
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 29
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 29
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 29
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 29
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 29
Treatment Options for Recurrent Anterior Skull Base Tumors 29
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial 29
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma 29
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 28
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area 28
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 28
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 28
Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series 28
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 27
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 27
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer 27
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 27
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 26
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 26
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 26
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 26
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures 26
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 25
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 25
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 25
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 25
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 25
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). 25
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience 25
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 25
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas 24
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 24
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 24
Druggable molecular targets in skin adnexal malignancies 24
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients 24
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 24
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure 24
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract 23
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies. 23
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract 23
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients 23
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) 22
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions 22
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 21
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 21
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target? 21
Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers 21
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted? 21
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 21
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 21
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy 21
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 21
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 21
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 21
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) 21
Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression? 20
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 20
Neoplasie testa collo 20
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials 20
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration 20
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 20
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak. 19
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 19
Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy 19
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 19
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 19
Sinonasal non-glandular cancers relapsing after multimodal treatments 19
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities 19
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience 18
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? 18
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 18
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 17
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer 17
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936) 16
Totale 2.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024344 0 0 0 0 0 0 0 47 52 45 83 117
2024/20251.091 40 5 3 7 7 107 49 66 188 270 176 173
2025/20261.268 476 185 162 216 148 81 0 0 0 0 0 0
Totale 2.703